Tada, T., Kumada, T., Hiraoka, A., Atsukawa, M., Hirooka, M., Tsuji, K., . . . Hiasa, Y. (2021). Impact of modified albumin–bilirubin grade on survival in patients with HCC who received lenvatinib. Sci Rep.
Citação norma ChicagoTada, Toshifumi, et al. "Impact of Modified Albumin–bilirubin Grade On Survival in Patients With HCC Who Received Lenvatinib." Sci Rep 2021.
MLA CitationTada, Toshifumi, et al. "Impact of Modified Albumin–bilirubin Grade On Survival in Patients With HCC Who Received Lenvatinib." Sci Rep 2021.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.